QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,954 signal articles · 507 in last 24h · 106,204 total before filter · latest 12m ago
507last 24h
2483last 7d
484● bullish (7d)
256● bearish (7d)
200publishers
AllMacro175Earnings1547M&A137Regulatory15Product8Analyst22
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearishshow all (incl. clickbait)
POET Technologies (POET) Soars 27% Ahead of This Week’s Earnings
Insider Monkey87d agobullish
POET Technologies (POET) Soars 27% Ahead of This Week’s Earnings

POET Technologies Inc. (NASDAQ:POET) is one of the 10 Stocks With Easy Double-Digit Returns. POET Technologies rallied for a second day on Monday, climbing 27.09 percent to close at $13.90 apiece, as investors resumed buying positions ahead of the results of its earnings performance this week. Based on its historical reporting dates, POET Technologies Inc. […]

Everpure Stock Rallies As Data Storage Player Nears Earnings Test
Investor's Business Daily87d agobullish
Everpure Stock Rallies As Data Storage Player Nears Earnings Test

Everpure stock jumped Monday ahead of the data storage company's earnings. The company, which recently changed its name from Pure Storage, is  rallying ahead of an earnings report due later this month. Everpure stock is up more than 13% at 88.80 in recent trading on the stock market today Monday.

A Look At CVS Health (CVS) Valuation After Earnings Beat And Raised 2026 Guidance
Simply Wall St.87d agobullish
A Look At CVS Health (CVS) Valuation After Earnings Beat And Raised 2026 Guidance

CVS Health (CVS) is back in focus after first quarter 2026 results and raised full year guidance, with management highlighting broad based strength across Aetna, Health Services, and Pharmacy & Consumer Wellness. See our latest analysis for CVS Health. After the earnings beat and guidance raise, the share price has climbed to US$90.55, with a 1 month share price return of 14.14% and a 1 year total shareholder return of 44.83%. This suggests momentum has picked up recently compared with longer...